Kusuda et al., 1988 - Google Patents
The efficacy of attenuated live bacterin of Pusteurella piscicids against pseudotuberculosis in yellowtailKusuda et al., 1988
View PDF- Document ID
- 7229052356635436084
- Author
- Kusuda R
- Hamaguchi M
- Publication year
- Publication venue
- Bull Eur Assoc Fish Pathol
External Links
Snippet
Materials and Methods Yellowtail about 28 g, were obtained fron a fish tarm in Kochi Pre {'ecture, Japan. The fish were kept in 800/plastic tanks supplied with running sea water at 21 Pasteurella piscicida strain OT-844'7 isolated in 1984 f'rom diseased yellowtail in Oita …
- 241001600434 Plectroglyphidodon lacrymatus 0 title abstract description 14
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A61K2039/523—Bacterial cells; Fungal cells; Protozoal cells expressing foreign proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55588—Adjuvants of undefined constitution
- A61K2039/55594—Adjuvants of undefined constitution from bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/025—Enterobacteriales, e.g. Enterobacter
- A61K39/0291—Yersinia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/245—Herpetoviridae, e.g. herpes simplex virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/002—Protozoa antigens
- A61K39/015—Hemosporidia antigens, e.g. Plasmodium antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/04—Mycobacterium, e.g. Mycobacterium tuberculosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Micro-organisms or materials therefrom
- A61K35/74—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Waldeland et al. | Live and killed vaccines against toxoplasmosis in mice | |
| Kusuda et al. | The efficacy of attenuated live bacterin of Pusteurella piscicids against pseudotuberculosis in yellowtail | |
| Jiménez de Bagüés et al. | Protective immunity to Brucella ovis in BALB/c mice following recovery from primary infection or immunization with subcellular vaccines | |
| Arko et al. | Neisseria gonorrhoeae: effects of systemic immunization on resistance of chimpanzees to urethral infection | |
| Paterson et al. | The immune response of Atlantic salmon, Salmo salar L., to the causative agent of bacterial kidney disease, Renibacterium salmoninarum | |
| Tollersrud et al. | Antibody responses in sheep vaccinated against Staphylococcus aureus mastitis: a comparison of two experimental vaccines containing different adjuvants | |
| JP3601602B2 (en) | Non-toxic microorganisms and their use: Salmonella | |
| US20040037851A1 (en) | Fusobacterium necrophorum vaccine and method for making such vaccine | |
| Evenberg et al. | Vaccine‐induced protective immunity against Aeromonas salmonicida tested in experimental carp erythrodermatitis | |
| Kanemori et al. | The role of extracellular protease produced by Vibrio anguillarum | |
| US6379677B1 (en) | Streptococcus iniae vaccine | |
| Howard | A prototype live oral cholera vaccine | |
| Cameron et al. | Immunization of mice against Corynebacterium pseudotuberculosis infection | |
| Watson et al. | Influence of adjuvants on the immune response of sheep to a novel Staphylococcus aureus vaccine | |
| WO1993016728A1 (en) | Improved vaccin against brucella abortus | |
| Marsden et al. | The influence of vaccine preparations on the induction of antigen specific responsiveness in rainbow troutOncorhynchus mykiss | |
| US20050129714A1 (en) | Vaccine against salmonid rickettsial septicaemia based on arthrobacter cells | |
| Cameron et al. | Studies on the enhancement of immunity to Corynebacterium pseudotuberculosis | |
| NZ206083A (en) | Cattle vaccine against moraxella bovis | |
| Holstad et al. | Corynebacterium pseudotuberculosis infection in goats VIII. The effect of vaccination against experimental infection | |
| US6019981A (en) | Modified live Edwardsiella ictaluri against enteric septicemia in channel catfish | |
| Velji et al. | Nature of the immune response in coho salmon Oncorhynchus kisutch following vaccination with Vibrio ordalii lipopolysaccharide by two different routes | |
| Bryner et al. | Vaccination of pregnant guinea pigs with Campylobacter fetus: effects of antigen dose, Campylobacter strain, and adjuvant type | |
| Kita et al. | Mechanism of the protective immunity against murine typhoid: persistence of Salmonella L forms in the liver after immunization with live-cell vaccines | |
| Waldhalm et al. | Efficacy of a bacterin prepared from Chlamydia psittaci grown in cell culture for experimental immunization of ewes |